Skip to main content
Premium Trial:

Request an Annual Quote

Febit Inks Biosecurity Development Deal with In-Q-Tel

NEW YORK (GenomeWeb News) – Febit today said that it has signed a strategic investment and technology development agreement with In-Q-Tel to further develop Febit’s Geniom technology for biosecurity applications.
 
The firms expect to improve the multiplex Geniom system for detection and classification of known and unknown pathogens.
 
“Febit’s partnership with In-Q-Tel enables us to focus on the field of pathogen detection, and further enhance an application-oriented device with well-defined requirements, similar to what we have developed in the field of microRNA analysis with the Geniom RT Analyzer,” Febit CEO Cord Staehler said in a statement.
 
In-Q-Tel is a non-profit investment firm created by the Central Intelligence Agency in 1999 with the goal of identifying and developing technology to support the mission of the US intelligence community.
 
Financial and other terms of the alliance were not disclosed.
 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.